Medicine:Andes virus infection

From HandWiki
Short description: Disease caused by a specific virus

This template is being used in the wrong namespace. To nominate this talk page for deletion, go to Miscellany for deletion.

Andes virus infection
Other namesANDV infection
Locations the Andes virus usually occurs.[1][2]
SpecialtyInfectious disease
SymptomsInitially: Fever, muscle aches, vomiting[3]
Later: Shortness of breath, cough, abdominal pain, low blood pressure[3]
ComplicationsHantavirus cardiopulmonary syndrome (HCPS), bleeding, heart arrhythmias, kidney problems[3]
Usual onset4 days to 8 weeks after exposure[3]
CausesAndes hantavirus (close contact and possible airborne)[3]
Diagnostic methodSupported by PCR or serology testing[3]
Differential diagnosisInfluenza, legionnaire's, leptospirosis, mycoplasma, Q fever[4]
TreatmentSupportive care[3]
FrequencyRare (mostly Argentina and Chile)[3]
Deaths35 to 50%[3]

Andes virus infection, or ANDV infection,[5] is a hantavirus infection by a specific type of hantavirus.

Severity of symptoms is variable.[3] Initially there may be fever, muscle aches, and vomiting.[3] This may be followed by shortness of breath, cough, abdominal pain, and low blood pressure, a complication known as hantavirus cardiopulmonary syndrome (HCPS).[3] Worsening may occur suddenly.[3] Onset is usually 2 to 4 weeks after exposure, but can be 4 days to 8 weeks.[3]

The virus typically circulates in rodents, particularly the long-tailed pygmy rice rat.[3] It can spread to people who come into contact with infected rodents or their droppings.[3] However, infected rodents do not appear ill.[3] It is the only hantavirus that is known to spread between people, typically by close contact; though possibly airborne.[3] Spread has been documented in the healthcare environment, including affected hospital staff.[3] Diagnosis may be supported by PCR or serology testing.[3]

Prevention involves avoiding rodents in the areas of the world were the disease occurs.[3] There is no specific treatment or vaccine, with management involving supportive care.[3] In severe cases, infected individuals may be intubated and receive oxygen therapy.[4] Extracorporeal membrane oxygenation (ECMO) may be another option.[3] The risk of death among those infected is 35 to 50%.[3]

Andes virus infection is rare.[3] It primarily occurs in central Andes mountains of the Argentina and Chile.[3][1][2] Cases are most common in the spring and summer and among people who spend time in rural areas.[3] It was initially described in 1995.[3] An outbreak started as late as 2026. The infection is named for the Andes mountains, where it was first discovered.

Signs and symptoms

Initial signs can easily be mistaken for the flu. Symptoms can appear as early as 4 days and up to 6 weeks after exposure.[6][7] The only way to diagnose Andes orthohantavirus is by testing the person's blood for Andes orthohantavirus genetic material or for corresponding antibodies.[7] Individuals are typically only infectious while they are showing symptoms such as having one or more of the following:[7]

  • Nausea or vomiting
  • Headache
  • Diarrhea
  • Muscle aches
  • Fever
  • Coughing
  • Shortness of breath
  • Fluid in lungs

Complications may include kidney failure.[8]

Cause

ANDV, lineage ANDV-Sout, is the only hantavirus for which person-to-person transmission has been described; all other human hantavirus infections are transmitted exclusively from animals to humans.[9][10][11] Several ANDV strains are co-circulating in Argentina (e.g. Bermejo, Lechiguanas, Maciel, Oran and Pergamino).[12][13]

Spread

The virus can spread from humans or rodents, and there are multiple potential routes of infection including:[6][7]

  • Breathing in the virus aerosols; stirred up rodent feces or urine
  • Direct contact with eyes, nose, or mouth after touching infected rodent, its feces, urine, or nesting material
  • Bite from infected rodent
  • Although rare, through direct or close contact with an infected person
  • Bodily fluids (blood, saliva, urine, or semen)

Risk is greatest among close contacts, such as sexual partners at 18%, and household contacts at 1%.[14] Though, there is concern of potential airborne spread.[3] People may also spread the disease before the onset of symptoms.[3]

Reservoir

In Argentina and Chile, the long-tailed rice rat, Oligoryzomys longicaudatus, and other species of the genus Oligoryzomys, have been documented as the reservoir for ANDV.[13][15][16]

Although it can be carried by humans and rodents, Andes orthohantavirus is most commonly found in the Oligoryzomys longicaudatus, a species of pygmy rat native to the Chile-Argentina region,[17] and in other cases, in the Abrothrix longipilis, a long-haired grass mouse.[18]

Virology

Classification

Andes orthohantavirus is a species of hantavirus, a group of enveloped, negative-sense single-stranded RNA virus, belonging to the family Hantaviridae and genus Orthohantavirus. All genera excluding hantavirus are air-borne viruses while the hantavirus is rodent-borne.[19] Transmission of the hantaviruses are through aerosol exposure to rodent bodily fluids.[20] Additionally, hantaviruses seem to cause no detectable cytopathology in vertebrate cell cultures.[20]

Genome and structure

The spherical virion of the hantavirus is typically 80-120 nm long and contains the segmented single-stranded genome.[21] The tri-segmented genome includes a S (small), M (medium), and L (large) segment that code for nucleocapsid (N), glycoproteins G1 and G2, and L protein respectively.[19] The S segment of the Andes virus contains 1876 nucleotides in total, while encoding a 547 nucleotide-long N protein.[22] Upon comparison of S and M segments to other variants, the Andes virus was found to form a lineage with viruses such as ESQ H-1/96, CH H-1/96 Bayou, and Black Creek Canal viruses.[22] When expressed, the M segment generates the glycoprotein precursor (GPC) which can be cleaved into the envelope Gn and Gc proteins.[23] The L protein encoded by the L segment possesses enzymatic functions that are involved within transcription and replication.[23]

In addition to these segments, the virion also contains RdRP which are all enclosed in an envelope.[24] Unlike the other four genera in the family the hantavirion segments also contain a complementary 3'-terminal nucleotide sequence to the 5'-terminal sequence. These nucleotide sequences are AUCAUCAUCUG... at the 3′ end and UAGUAGUAUGC... at the 5′ end.[20]

Pathophysiology

The hantavirus replication takes place strictly in the cytoplasm of a host cell primarily targeting endothelial cells.[25] During early infection, Andes virus can produce a weak, innate immune response in the cell.[25] The entry and uncoating of the virus begins when the virion attaches to cell receptors on the surface of the host cell, which then brings in the virus via endocytosis.[21] By a process called pH-dependent fusion between the virion and the endosomal membrane, nucleocapsids enter the cytoplasm.[19] The virus genome contains its own RNA-dependent RNA polymerase (RdRp) which directs both transcription and replication of the viral genome. Once the nucleocapsids are released, RdRp initiates transcription by binding to the encapsidated segments.[26] While M segment mRNAs are translated by membrane-bound ribosomes, L and S segment mRNAs are translated by free ribosomes. Once transcribed, the mRNA is capped by L proteins via Cap snatching.[27] These capped RNA fragments can then be transferred to L protein, to be further trimmed in length by the endonuclease and used by the RdRp to initiate viral mRNA synthesis.[23] Replication is terminated when the plasma membrane begins to fuse with cytoplasmic vesicles and mature virions are released.[20]

Prevention

When visiting geographical locations where Andes virus has been documented, people should avoid areas of high rodent populations where the virus is more likely to be found and transmitted quickly and easily from rodent to the next.[6][28] Properly disinfecting living spaces and areas where rodents may have been present will kill the virus before it is able to be contracted. To prevent transmission from contact with infected humans, individuals, infected or not, should hand-wash frequently, abstain from kissing or sexual activity with one another, and avoid sharing spaces of close confinement for long periods of time.[6][7][28]

Treatment

There is no current treatment, cure, or vaccine available for illness caused by Andes virus. However, if patients seek medical attention quickly, early symptoms can be abated through intensive care or intubation, if necessary, for patients with severe breathing difficulties.[6][7]

Evidence does not support the use of either ribavirin or corticosteroids.[3]

Epidemiology

Location of the various ANDV outbreaks in blue, with all occurring in central Argentina and Chile. Not shown: the 2026 outbreak on a cruiseship that left Ushuaia, and did island-hopping in the Atlantic Ocean.

ANDV typically causes disease in Argentina and Chile.[29]

Argentina

In Argentina the North (Salta, Jujuy), Centro (Buenos Aires, Santa Fe Province, and Entre Ríos), Northeast (Misiones) and Patagonia (Neuquén, Río Negro, and Chubut) see cases.[3]

In Argentina, 1,350 cases of HPS have occurred up to 2016 (from various hantaviruses).[30] It is estimated (year 2014) that about 16% of these cases were due to ANDV,[31] making it the most common cause in that country.[32] At least another 34 cases of ANDV occurred in late 2018 and early 2019 in Argentina.[33]

Argentina reported 86 cases of HPS in 2025, though likely only some of these were due to the Andes virus.[34]

Chile

In Chile cases occur in Región de Los Lagos.[3]

In 2025 in Chile 44 cases occurred, probably due to ANDV.[35]

Other

Rare cases of Andes virus in the United States and Europe have occurred due to travel from Argentina or Chile.[3] In 2026 an outbreak occurred on the ship MV Hondius.

Prognosis

It appears more lethal than some other hantaviruses having a mortality rate between 40% and 50% in South America.[6][36]

The critical phase of the disease is fairly short, if people can survive it.[4] There also appears to be limited permanent tissue damage.[4]

History

Andes virus was first identified during outbreaks in Chile and Argentina. In 1995, it was characterized in Argentina on the basis of specimens from a patient who had died from HPS complications.[9] It has been responsible for the most recorded cases in Argentina and Chile.[9][8]

Research

An animal model is available for ANDV, as it causes lethal disease in the Syrian hamster (Mesocricetus auratus) that closely models the course of disease progression in humans, including a rapid progression from first symptoms to death, which is characterized by fluid in the pleural cavity and the histopathology of the lungs and spleen.[37] Lethality of ANDV in hamsters is not true of all viruses causing HCPS; hamsters infected with Sin Nombre virus, for example, show no symptoms of disease.[37] The availability of this model allows for the study of various drugs and other treatments that may affect the treatment of all HCPS-causing hantavirus infections.[citation needed]

References

  1. ↑ 1.0 1.1 Andreo, V; Neteler, M; Rocchini, D; Provensal, C; Levis, S; Porcasi, X; Rizzoli, A; Lanfri, M et al. (14 January 2014). "Estimating hantavirus risk in southern Argentina: a GIS-based approach combining human cases and host distribution.". Viruses 6 (1): 201–22. doi:10.3390/v6010201. PMID 24424500. 
  2. ↑ 2.0 2.1 Ulloa-Morrison, R; Pavez, N; Parra, E; Lopez, R; Mondaca, R; Fernandez, P; Kraunik, D; Sanhueza, C et al. (December 2024). "Critical care management of hantavirus cardiopulmonary syndrome. A narrative review.". Journal of Critical Care 84. doi:10.1016/j.jcrc.2024.154867. PMID 39024823. 
  3. ↑ 3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10 3.11 3.12 3.13 3.14 3.15 3.16 3.17 3.18 3.19 3.20 3.21 3.22 3.23 3.24 3.25 3.26 3.27 3.28 3.29 3.30 3.31 3.32 3.33 "Andes hantavirus: epidemiology, outbreaks and guidance" (in en). https://www.gov.uk/guidance/andes-hantavirus-epidemiology-outbreaks-and-guidance. 
  4. ↑ 4.0 4.1 4.2 4.3 "Clinician Brief: Hantavirus Pulmonary Syndrome (HPS)" (in en-us). CDC. 8 May 2026. https://www.cdc.gov/hantavirus/hcp/clinical-overview/hps.html. 
  5. ↑ https://www.gov.uk/guidance/andes-hantavirus-epidemiology-outbreaks-and-guidance. Gov.uk. Retrieved 2026-05-19
  6. ↑ 6.0 6.1 6.2 6.3 6.4 6.5 "Andes Virus - an overview | ScienceDirect Topics". https://www.sciencedirect.com/topics/medicine-and-dentistry/andes-virus. 
  7. ↑ 7.0 7.1 7.2 7.3 7.4 7.5 "Fact Sheet about Andes Virus | Hantavirus | DHCPP | CDC". 2019-02-20. https://www.cdc.gov/hantavirus/resources/andes-virus.html. 
  8. ↑ 8.0 8.1 "Andes virus". https://medical-dictionary.thefreedictionary.com/Andes+virus. 
  9. ↑ 9.0 9.1 9.2 "Person-to-person transmission of Andes virus". Emerging Infectious Diseases 11 (12): 1848–53. December 2005. doi:10.3201/eid1112.050501. PMID 16485469. 
  10. ↑ "An outbreak of hantavirus pulmonary syndrome, Chile, 1997". Emerging Infectious Diseases 4 (4): 687–94. October–December 1998. doi:10.3201/eid0404.980425. PMID 9866751. 
  11. ↑ "Seroprevalence of antibodies to hantavirus in health care workers and other residents of southern Argentina". Clinical Infectious Diseases 27 (4): 895–6. October 1998. doi:10.1086/517161. PMID 9798052. 
  12. ↑ "Genetic diversity, distribution, and serological features of hantavirus infection in five countries in South America". J Clin Microbiol 38 (8): 3029–3035. August 2000. doi:10.1128/JCM.38.8.3029-3035.2000. PMID 10921972. 
  13. ↑ 13.0 13.1 "Genetic diversity and epidemiology of hantaviruses in Argentina". The Journal of Infectious Diseases 177 (3): 529–38. March 1998. doi:10.1086/514221. PMID 9498428. 
  14. ↑ Ferres, M; Vial, P; Marco, C; Yanez, L; Godoy, P; Castillo, C; Hjelle, B; Delgado, I et al. (1 June 2007). "Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in chile.". The Journal of Infectious Diseases 195 (11): 1563–71. doi:10.1086/516786. PMID 17471425. 
  15. ↑ "An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia". Emerging Infectious Diseases 3 (2): 171–4. April–June 1997. doi:10.3201/eid0302.970210. PMID 9204298. 
  16. ↑ "Seasonal variation in prevalence of antibody to hantaviruses in rodents from southern Argentina". Tropical Medicine & International Health 6 (10): 811–6. October 2001. doi:10.1046/j.1365-3156.2001.00788.x. PMID 11679129. 
  17. ↑ "Hantavirus | virus". https://www.britannica.com/science/hantavirus. 
  18. ↑ "Ecology, genetic diversity, and phylogeographic structure of andes virus in humans and rodents in Chile". Journal of Virology 83 (6): 2446–59. March 2009. doi:10.1128/JVI.01057-08. PMID 19116256. 
  19. ↑ 19.0 19.1 19.2 "Virology | Hantavirus | DHCPP | CDC". 2019-02-26. https://www.cdc.gov/hantavirus/technical/hanta/virology.html. 
  20. ↑ 20.0 20.1 20.2 20.3 International Committee on Taxonomy of Viruses (ICTV) (2019). "Bunyaviridae". https://ictv.global/report/chapter/peribunyaviridae. 
  21. ↑ 21.0 21.1 "Hantaviral Proteins: Structure, Functions, and Role in Hantavirus Infection". Frontiers in Microbiology 6: 1326. November 2015. doi:10.3389/fmicb.2015.01326. PMID 26640463. 
  22. ↑ 22.0 22.1 "Genetic characterization and phylogeny of Andes virus and variants from Argentina and Chile". Virus Research 50 (1): 77–84. July 1997. doi:10.1016/S0168-1702(97)00053-1. PMID 9255937. 
  23. ↑ 23.0 23.1 23.2 "The N terminus of Andes virus L protein suppresses mRNA and protein expression in mammalian cells". Journal of Virology 87 (12): 6975–85. June 2013. doi:10.1128/JVI.00043-13. PMID 23576516. 
  24. ↑ "Hantavirus structure--molecular interactions behind the scene". The Journal of General Virology 93 (Pt 8): 1631–44. August 2012. doi:10.1099/vir.0.042218-0. PMID 22622328. 
  25. ↑ 25.0 25.1 "Andes virus nucleocapsid protein interrupts protein kinase R dimerization to counteract host interference in viral protein synthesis". Journal of Virology 89 (3): 1628–39. February 2015. doi:10.1128/JVI.02347-14. PMID 25410857. 
  26. ↑ "Hantavirus infection". Journal of the American Society of Nephrology 16 (12): 3669–79. December 2005. doi:10.1681/ASN.2005050561. PMID 16267154. 
  27. ↑ "ViralZone page". https://viralzone.expasy.org/7079?outline=all_by_species. 
  28. ↑ 28.0 28.1 "Andes Virus (Hantavirus) in Argentina - Watch - Level 1, Practice Usual Precautions - Travel Health Notices | Travelers' Health | CDC". https://wwwnc.cdc.gov/travel/notices/watch/andes-virus-hantavirus-argentina. 
  29. ↑ "Sin Nombre Virus and the Emergence of Other Hantaviruses: A Review of the Biology, Ecology, and Disease of a Zoonotic Pathogen". Biology (Basel) 12 (11): 1143. 9 November 2023. doi:10.3390/biology12111413. PMID 37998012. 
  30. ↑ "Hantavirus: an overview and advancements in therapeutic approaches for infection". Front Microbiol 14. 12 October 2023. doi:10.3389/fmicb.2023.1233433. PMID 37901807. 
  31. ↑ Andreo, Veronica; Neteler, Markus; Rocchini, Duccio; Provensal, Cecilia; Levis, Silvana; Porcasi, Ximena; Rizzoli, Annapaola; Lanfri, Mario et al. (14 January 2014). "Estimating Hantavirus Risk in Southern Argentina: A GIS-Based Approach Combining Human Cases and Host Distribution". Viruses 6 (1): 201–222. doi:10.3390/v6010201. PMID 24424500. 
  32. ↑ Avšič-Županc, T.; Saksida, A.; Korva, M. (April 2019). "Hantavirus infections". Clinical Microbiology and Infection 21: e6–e16. doi:10.1111/1469-0691.12291. PMID 24750436. 
  33. ↑ Martínez, Valeria P.; Di Paola, Nicholas; Alonso, Daniel O.; Pérez-Sautu, Unai; Bellomo, Carla M.; Iglesias, Ayelén A.; Coelho, Rocio M.; López, Beatriz et al. (3 December 2020). ""Super-Spreaders" and Person-to-Person Transmission of Andes Virus in Argentina". New England Journal of Medicine 383 (23): 2230–2241. doi:10.1056/NEJMoa2009040. PMID 33264545. 
  34. ↑ "Statement from the International Hantavirus Society and members of the international hantavirus research and clinical community regarding Andes virus transmission and the current outbreak investigation". https://zenodo.org/records/20134326. 
  35. ↑ "MINSAL refuerza alerta epidemiológica por Hantavirus ante aumento de casos fatales en el país". 2 February 2026. https://saludpm.cl/2026/02/02/minsal-refuerza-alerta-epidemiologica-por-hantavirus-ante-aumento-de-casos-fatales-en-el-pais/. 
  36. ↑ "What Do We Know about How Hantaviruses Interact with Their Different Hosts?". Viruses 8 (8): 223. August 2016. doi:10.3390/v8080223. PMID 27529272. 
  37. ↑ 37.0 37.1 "A lethal disease model for hantavirus pulmonary syndrome". Virology 289 (1): 6–14. October 2001. doi:10.1006/viro.2001.1133. PMID 11601912. 

Further reading

Classification



Retrieved from "https://handwiki.org/wiki/index.php?title=Medicine:Andes_virus_infection&oldid=4429634"